Total Funding
94
76
Total FundingPost-IPO Equity raised
Growth Score 94 in past quarter
12 pts
Heat Score 76 in past quarter
19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
152760
Cleo Diagnostics is bringing to market a simple blood test for the accurate and early diagnosis of ovarian cancer.
- Pauline Moffatt: Company Secretary & Financial Controller
About the Company
Cleo Diagnostics is a biotechnology company developing blood-based tests for the detection of ovarian cancer. Its work is based on identifying specific protein markers in blood samples to support diagnosis. The company focuses on translating laboratory research into clinically usable diagnostic tools for healthcare settings.